The same combination also enhanced activation and expression of Nrf2 and ultimately its target genes GSTP, NQO1, and superoxide dismutase gene SOD. Modulation of these two pathways resulted in reduced proliferation of pancreatic cancer PANC-1 cells. Here, NFE2L2 is linked to pancreatic neoplasm.